Genmab A/S (GMAB) Reports FY EPS of $15.37

Genmab A/S (NASDAQ: GMAB) reported FY EPS of $15.37. Revenue for the period came in at $3.72 billion.

For earnings history and earnings-related data on Genmab A/S (GMAB) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Datavault AI to acquire CyberCatch for $94.5M in all-cash deal
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c